ArticleACS omega2025
Active Stacking-Deep Learning with Strategic Sampling for Small and Imbalanced Chemical Toxicity Prediction.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Data-efficient learning for accurate identification of MAPK1 inhibitors using an active meta-deep learning framework.Journal of cheminformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major challenges in toxicity prediction include dealing with imbalanced and limited data sets, especially when evaluating the harmful potential of chemicals. These issues often lead to poor predictive model performance. Stacking ensemble learning enhances performance by combining predictions from multiple base models, enabling the stack model to improve overall generalization. Active learning (AL), on the other hand, reduces the need for large-scale data sets by effectively training models using carefully selected samples. One effective approach to address data imbalance is the use of strategic sampling techniques. Hereby, we introduce an active stacking-deep learning framework that integrates deep neural networks (DNNs), including a convolutional neural network (CNN), a bidirectional long short-term memory (BiLSTM), and an attention mechanism, with strategic data sampling to tackle challenges posed by imbalanced and limited data, ultimately improving the performance of a chemical risk assessment predictive model. In this study, we focused on thyroid-disrupting chemicals (TDCs) that target thyroid peroxidase, as they are linked to thyroid dysfunction, making it essential to evaluate their risks to human health. Using stacking ensemble learning with strategic sampling within an AL framework, our approach achieved an MCC of 0.51, AUROC of 0.824, and AUPRC of 0.851. Although performance decreased across varying test ratios, our uncertainty-based method demonstrated superior stability under severe class imbalance. While a full-data stacking ensemble trained with strategic sampling performs slightly better in MCC, our method achieves marginally higher AUROC and AUPRC, requiring up to 73.3% less labeled data. Molecular docking further validated our predictions, especially for highly toxic compounds, reinforcing the reliability of our framework in identifying TDCs. These findings highlight how active stacking-deep learning with strategic sampling can transform toxicity prediction, offering a more accurate and data-efficient alternative to traditional chemical risk assessment methods.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.